Article Patent Law | 12/01/24 | 3 min. | François Pochart Pierre-Olivier Ally
On 11 January 2024, the Court of Justice rendered a judgment in Case C-473/22 between Mylan and Gilead.
As a reminder, Gilead had requested and obtained interim injunctive relief in Finland against Mylan. These provisional measures were later overturned, and Mylan sought damages to be compensated. In its opinion of 21 September 2023, the Advocate General argued that Article 9(7) of Directive 2004/48/EC (the “Directive”) should be construed as incompatible with Member States’ regulations providing for strict liability regimes[1].
However, the Court adopted a contrary solution.
In its analysis to determine whether the Finnish strict liability regime is in compliance with the Directive, specifically Article 3, the Court examined three essential criteria. The Court ruled that:
We can only laud the clarifications provided by the Court of Justice in contrast to the Bayer[2] ruling. However, it remains to be seen how national courts will interpret the circumstances of the case, including “whether the defendant played a part in the occurrence of the injury”, to adjust the amount of damages sought.
[2] Bayer v. Richter, Judgment of 12 September 2019 of the Court of Justice of the European Union, No C-688/17.